Related references
Note: Only part of the references are listed.Comparison of the Seven Interleukin-32 Isoforms' Biological Activities: IL-32θ Possesses the Most Dominant Biological Activity
Saerok Shim et al.
FRONTIERS IN IMMUNOLOGY (2022)
A Paradoxical Effect of Interleukin-32 Isoforms on Cancer
Saerok Shim et al.
FRONTIERS IN IMMUNOLOGY (2022)
A Critical Overview of Interleukin 32 in Leishmaniases
Fatima Ribeiro-Dias et al.
FRONTIERS IN IMMUNOLOGY (2022)
The role of Interleukin-32 in autoimmunity
Rafael Albuquerque et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2021)
Axial Spondyloarthritis: Current Advances, Future Challenges
Robert D. Inman
JOURNAL OF RHEUMATIC DISEASES (2021)
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension
Paola Di Benedetto et al.
ARTHRITIS RESEARCH & THERAPY (2020)
Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus
Oh Chan Kwon et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2019)
Pathogenesis and therapeutic interventions for ANCA-associated vasculitis
Daigo Nakazawa et al.
NATURE REVIEWS RHEUMATOLOGY (2019)
Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis: a retrospective observational study
Kazuki M. Matsuda et al.
ARTHRITIS RESEARCH & THERAPY (2019)
Structural Characteristics of Seven IL-32 Variants
Dong Hyun Sohn et al.
IMMUNE NETWORK (2019)
Role of IL-32 Gamma on Bone Metabolism in Autoimmune Arthritis
Oh Chan Kwon et al.
IMMUNE NETWORK (2018)
Psoriatic Arthritis
Christopher T. Ritchlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Interleukin 32, inflammation and cancer
Jin Tae Hong et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Interleukin-32 Gamma Stimulates Bone Formation by Increasing miR-29a in Osteoblastic Cells and Prevents the Development of Osteoporosis
Eun-Jin Lee et al.
SCIENTIFIC REPORTS (2017)
Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis
Dinesh Khanna et al.
JOURNAL OF SCLERODERMA AND RELATED DISORDERS (2017)
Association of Plasma IL-32 Levels and Gene Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population
Yanyun Wang et al.
DISEASE MARKERS (2016)
IL-32: A Novel Pluripotent Inflammatory Interleukin, towards Gastric Inflammation, Gastric Cancer, and Chronic Rhino Sinusitis
Muhammad Babar Khawar et al.
MEDIATORS OF INFLAMMATION (2016)
High level of interleukin-32 gamma in the joint of ankylosing spondylitis is associated with osteoblast differentiation
Eun-Ju Lee et al.
ARTHRITIS RESEARCH & THERAPY (2015)
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?
Chandra Mohan et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Biomarkers in rheumatic diseases: how can they facilitate diagnosis and assessment of disease activity?
Chandra Mohan et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
A panoramic spectrum of complex interplay between the immune system and IL-32 during pathogenesis of various systemic infections and inflammation
Babar Khawar et al.
EUROPEAN JOURNAL OF MEDICAL RESEARCH (2015)
Interaction network mapping among IL-32 isoforms
Jeong-Woo Kang et al.
BIOCHIMIE (2014)
Three cases of lupus nephritis patients with serum interleukin-32γ detection
M. Inoue et al.
LUPUS (2014)
Serum levels of cytokines in systemic lupus erythematosus. Association study in a Chinese population
M. Zhang et al.
ZEITSCHRIFT FUR RHEUMATOLOGIE (2014)
Interleukin-32 in Inflammatory Autoimmune Diseases
Soohyun Kim
Immune Network (2014)
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
J. C. Jennette et al.
ARTHRITIS AND RHEUMATISM (2013)
Novel insights into the biology of interleukin-32
Leo A. B. Joosten et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
IL-32 with potential insights into rheumatoid arthritis
Wang-Dong Xu et al.
CLINICAL IMMUNOLOGY (2013)
Interleukin-32: A predominantly intracellular proinflammatory mediator that controls cell activation and cell death
Bas Heinhuis et al.
CYTOKINE (2012)
Increased expression of interleukin-32 in the inflamed ileum of ankylosing spondylitis patients
Francesco Ciccia et al.
RHEUMATOLOGY (2012)
Elevated interleukin-32 expression in granulomatosis with polyangiitis
Suyoung Bae et al.
RHEUMATOLOGY (2012)
Expression of Interleukin-32 in the Inflamed Arteries of Patients With Giant Cell Arteritis
Francesco Ciccia et al.
ARTHRITIS AND RHEUMATISM (2011)
IL-32γ Induces the Maturation of Dendritic Cells with Th1-and Th17-Polarizing Ability through Enhanced IL-12 and IL-6 Production
Mi Young Jung et al.
JOURNAL OF IMMUNOLOGY (2011)
MECHANISMS OF DISEASE The Pathogenesis of Rheumatoid Arthritis
Iain B. McInnes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Effect of Interleukin-32γ on Differentiation of Osteoclasts From CD14+Monocytes
Yong-Gil Kim et al.
ARTHRITIS AND RHEUMATISM (2010)
Tumor Necrosis Factor α-Induced Interleukin-32 Is Positively Regulated via the Syk/Protein Kinase Cδ/JNK Pathway in Rheumatoid Synovial Fibroblasts
Se Hwan Mun et al.
ARTHRITIS AND RHEUMATISM (2009)
Identification of the most active interleukin-32 isoform
Ji-Da Choi et al.
IMMUNOLOGY (2009)
Interleukin-32 Promotes Osteoclast Differentiation but Not Osteoclast Activation
Guillaume Mabilleau et al.
PLOS ONE (2009)
IL-32, a Novel Proinflammatory Cytokine in Chronic Obstructive Pulmonary Disease
Fiorella Calabrese et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Proteinase 3 is an IL-32 binding protein
D Novick et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
IL-32, a proinflammatory cytokine in rheumatoid arthritis
LAB Joosten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Interactions between IL-32 and tumor necrosis factor alpha contribute to the exacerbation of immune-inflammatory diseases
Hirofumi Shoda et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Interleukin-32: A cytokine and inducer of TNF alpha
SH Kim et al.
IMMUNITY (2005)
Share Paper
